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Edited by Takashi GojoboriAbstract To explore whether there exist correlations between
human gene expressions and corresponding sequence features,
the expression levels for 81 oncogenes in 24 human tissues were
collected and correlated with 159 sequence features. It was found
that there do exist signiﬁcant correlations between them, some of
which are of signiﬁcance to understanding translational selection
on sequence features of human genes and some have important
implications for diagnosing cancers.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Due to the great theoretical signiﬁcance and application
value, there is growing interest in identifying the factors that
aﬀect gene expression. Early eﬀorts in this area succeeded in
revealing signiﬁcant correlations between gene expression
levels and codon usage bias (CUB) for unicellular organisms
(e.g., Escherichia coli and Saccharomyces cerevisiae), that is,
highly expressed genes exhibit a stronger codon bias than
lowly expressed genes. This correlation can be attributed to
the diﬀerent tRNA abundance of respective codons [1,2] and
has led to the establishment of the E. coli/Yeast paradigm on
CUB which claimed that the translational selection pressure
represents a major evolutionary force to shape the synony-
mous codon usage pattern [3,4].
However, when the investigation turned to multicellular
organisms, the situation became much more complex due to,
in part, the gene tissue-speciﬁc expression of genes. Previous
studies showed that there exists a correlation between genes’
expression level and codon usage bias for invertebrate organ-
isms Caenorhabditis elegans (Spearman’s rank correlation coef-
ﬁcient rS = 0.30, P < 10131) [5] and Drosophila melanogaster
[6]. As to vertebrates, there exists heated debate on the exis-Abbreviations: CDS, protein-coding sequence; CUB, codon usage bias;
GC3, GC content at third codon position; FDR, false discovery rate
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doi:10.1016/j.febslet.2007.08.018tence or not of such a correlation. Although Musto et al.
revealed a signiﬁcant correlation between codon usage and
gene expression level measured by ESTs (expressed sequence
tags) in Xenopus laevis (r = 0.23, P < 0.0001) [7], whether
the correlation exists for mammals remains ambiguous. For
example, in a comparison study on rodents, Mus musculus
and Rattus norvegicus, Wolfe and Sharp reported a lack of
gene-expression-related constraint on codon usage [8], while
Konu and Li observed a signiﬁcant correlation between
mRNA expression level and GC content at the third codon
position (r = 0.21, P = 0.0026 for mouse and r = 0.246,
P = 0.01 for rat, respectively) [9]. Moreover, it remains unclear
whether such a correlation holds for human. A notable work
by Plotkin et al. reported the tissue-speciﬁc codon usage of
brain-speciﬁc genes and suggested that the expression of
human genes can be predicted by their sequence features in
diﬀerent tissues [10]. Nevertheless, a recent work by Se´mon
et al. challenged this conclusion by demonstrating that the
tissue-speciﬁcity of synonymous codon usage is very weakly
correlated with translational selection and thus the correlation
is of no value for genes’ expression level prediction [11].
As the prior conclusions were based on the expression of
overall genes, it is interesting to know the outcome for a spe-
cial subset of genes, e.g., human oncogenes. Due to the great
value of examining human oncogene expression in cancer pre-
vention and therapy, a large number of tissue-speciﬁc expres-
sion data have been accumulated for human oncogenes,
which provided us with a good opportunity to address the rela-
tionships between human gene expressions and sequence com-
positional features. The results are expected to provide some
new clues to understanding the translational selection on
sequence features of human oncogenes and facilitating the
diagnosis of human tumors as well.2. Materials and methods
2.1. Data preparation
Considering the high quality and wide use of SOURCE database
(located at http://smd.stanford.edu [12]) in cancer research [13–15], this
database was employed in the present study to derive oncogenes and
associated expression information. Totally, 81 oncogenes and corre-
sponding normalized tissue-speciﬁc gene expression proﬁles were col-
lected. Following the links provided by the database, the protein-
coding sequences (CDSs) of oncogenes were downloaded from NCBI
(GenBank Release 156.0).
According to the oncogene classiﬁcation, the presently collected
oncogenes cover most functional classes, which include: (i) growth fac-
tor receptors (e.g., EGFR, fms, kit and ros); (ii) signal transducers,blished by Elsevier B.V. All rights reserved.
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brane-associated G proteins (e.g., H-ras, N-ras), GTPase exchange fac-
tor (vav), serine/threonine kinases (e.g., raf-1, pim-1) and cytoplasmic
regulators (crk); (iii) transcription factors (e.g., fos, jun, myc, myb,
rel, ski, ets-1, ets-2 and erbA2); (iv) others, such as programmed cell
death regulators (bcl-2). A detailed list of these oncogenes as well as
their expression status in diﬀerent tissues can be found in Supplemen-
tary Table 1.
To avoid statistical bias, an all-against-all pair-wise alignment was
performed for the 81 oncogenes by using the Needle program in EM-
BOSS software package (which implements the accurate Needle-
Wunsch global alignment algorithm). The results showed that any
two sequences in the dataset have a similarity score less than 80%
and the average similarity score of this dataset is less than 30%, which
means that the sequences are diverse enough to achieve reliable statis-
tics. Furthermore, 24 tissues with more than 30 expressed oncogenes
were selected to guarantee the reliability of statistical analysis. Some
basic information for the presently used dataset is listed in Table 1.
2.2. Sequence compositional features
With an attempt to explore the correlations between tissue-speciﬁc
expressions of human oncogenes and sequence compositional features,
159 indicators were calculated for each CDS by writing Python scripts,
some of which are associated with CUB characterization. These fea-
tures can be categorized into four groups: (i) nucleotide compositional
features, which include base contents, phase-speciﬁc base contents, GC
content and GC3 content (which denotes the GC content at the third
codon position for the 59 synonymous codons, excluding the ﬁve non-
synonymous codons, namely, the codons coding for methionine and
tryptophan and the three stop codons); (ii) codon frequency features
(occurrence numbers for all the 61 sense codons in the CDS divided
by the total number of codons in the sequence); (iii) amino acid fre-
quency features (occurrence numbers for all the 20 amino acids divided
by the total number of amino acids for the CDS); (iv) synonymous
codon usage features (percentage of each synonymous codon in each
codon family that codes for the same amino acid). It should be pointed
out that not all of the features are independent to each other. ForTable 1
Statistics of tissue-speciﬁc oncogene expression
Tissue Gene number Average sequence length Average expr
Embryonic tissue 51 1911.1 5.7
Stomachc 55 1819.4 6.8
Kidney 76 1944.4 13.9
Liver 63 1932.1 9.6
Mammary gland 64 1885.9 7.9
Bone 65 1952.5 5.7
Lung 76 2025.2 19.7
Colonc 64 1840.2 10.2
Lymph node 58 1763.2 7.6
Brain 78 2005.9 43.3
Ovary 71 1962.7 7.0
Pancreas 64 1901.0 11.0
Prostate 67 2012.2 10.2
Skinc 64 1974.0 12.5
Testis 75 1996.3 14.2
Bladder 38 2008.1 3.8
Cervix 45 1925.4 6.3
Uterus 74 2054.2 17.2
Vascular 44 1772.3 7.4
Nerve tissuec 43 1904.4 4.7
Small intestinec 46 1893.6 4.0
Bone marrow 48 1768.6 5.7
Salivary gland 31 1881.4 4.1
Tracheac 50 2055.1 14.8
aNormalized expression data are indicated in parentheses.
bFeature that has the smallest P-value for each tissue.
cTissues without signiﬁcant (at a level of P-value <0.01) correlations.
dNucleotide compositional features.
eCodon frequency features.
fAmino acid frequency features.
gSynonymous codon usage features.example, when the codon frequency of a CDS is given, the amino acid
frequency of the corresponding protein sequence can be uniquely
determined. Nevertheless, the interdependence of these features does
not degrade the quality of each feature as a factor to correlate with
mRNA expression level, because these features may correspond to dif-
ferent regulation levels of gene expression.2.3. Correlation analysis
Open source statistical software R (‘‘GNU S’’) was used to do non-
parametric Spearman’s rank correlation analysis. P-values lower than
0.01 were considered statistically signiﬁcant and the features with such
P-values were called signiﬁcant features. The feature that has the
smallest P-value for each tissue is called the most signiﬁcant feature.
For the correction of multiple testing, false discovery rate (FDR)
[16–19] was controlled for all the correlations through converting P-
values to q-values by employing a recently developed R package [20].
A detailed description of the FDR analysis can be found in the Supple-
mentary data.3. Results
3.1. Proﬁle of signiﬁcant features
Through analyzing the relationships between human onco-
gene expression levels and 159 sequence compositional features
in 24 tissues, 3816 correlations were obtained, in which 112 are
signiﬁcant (P < 0.01) (Supplementary Table 2). In these signif-
icant features, 23 are nucleotide compositional features, 41 are
codon frequency features, 19 are amino acid frequency features
and 29 are synonymous codon usage features. It should be
pointed out that the adopted threshold for signiﬁcant level
(P < 0.01) is not extremely low. Therefore, approximately 38
(1% of total number 3816) features may be signiﬁcant byession Highest expressed oncogenea P-value rS value Feature
b
RHOA (46) 0.00062 0.46 C1d
RHOA (40) 0.01905 0.32 C1d
RHOB (218) 0.00914 0.30 G2d
EIF3S6 (57) 0.00240 0.38 G2d
EIF3S6 (38) 0.00148 0.39 G2d
RHOA (53) 0.00079 0.41 ACGe
RHOA (104) 0.00647 0.31 ACGe
FOS (73) 0.01140 0.31 CCAe
RHOA (33) 0.00003 0.52 CCCe
FOS (521) 0.00939 0.29 GTCe
EVI1 (66) 0.00114 0.38 GTCe
FOS (63) 0.00231 0.37 GTCe
EIF3S6 (61) 0.00791 0.32 TCAe
RHOA (86) 0.01383 0.31 TGCe
EIF3S6 (154) 0.00004 0.46 TGCe
EIF3S6 (19) 0.00535 0.44 Glyf
FOS (52) 0.00551 0.41 Hisf
FOS (190) 0.00218 0.35 Hisf
FOS (66) 0.00364 0.43 Hisf
JUN (38) 0.01114 0.38 Metf
EVI1 (37) 0.04964 0.29 Phef
EIF3S6 (63) 0.00122 0.45 AGG(R)g
EIF3S6 (33) 0.00499 0.49 CGT(R)g
FOSB (291) 0.01130 0.36 GCT(A)g
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results. Nevertheless, the majority of these signiﬁcant features
are informative.
The results show that the signiﬁcant features distribute
unevenly among tissues. For instance, some tissues (e.g., lymph
node, testis, bone marrow, etc.) hold multiple signiﬁcant fea-
tures, while some (e.g., colon, nerve tissue, skin, small intes-
tine, stomach and trachea) have no signiﬁcant features (at a
level of P < 0.01) (Supplementary Table 2). On the other hand,
some features are signiﬁcant in multiple tissues. For example,
G2 (guanine at the second codon position), C1 (cytosine at
the ﬁrst codon position) and GTC are signiﬁcant in 6, 5 and
4 tissues, respectively, while AAA, TTT, Gly, His and Asp
are in three tissues (Supplementary Table 2), which implies
that some common mechanisms may be involved in the regu-
lation of gene expression in diﬀerent tissues.
3.2. The most signiﬁcant features
The most signiﬁcant features that have the lowest P-value
for each tissue are listed in Table 1. Among the most signiﬁ-
cant features with P < 0.01, four (three G2 and one C1) are
nucleotide compositional features (corresponding to kidney,
liver, mammary gland and embryonic tissue), eight (three
GTC, two ACG, one CCC, TCA and TGC) are codon
frequency features (corresponding to brain, ovary, pancreas,
bone, lung, lymph node, prostate and testis), four (three His
and one Gly) are amino acid frequency features (correspond-
ing to cervix, uterus, vascular and bladder), two (AGG(R),
CGT(R)) are synonymous codon usage features (correspond-
ing to bone marrow and salivary gland).Table 2
Signiﬁcant features derived from false discovery rate (FDR) control
Tissue Feature q-valuea
Bone ACG 0.12344*
Bone marrow G2 0.17037
Bone marrow GGC 0.17401
Bone marrow GTT 0.14337*
Bone marrow AGG(R) 0.13798*
Bone marrow GTT(V) 0.17472
Embryonic tissue C1 0.11535*
Liver G2 0.17461
Liver ATG 0.17581
Liver Met 0.17686
Liver AGG(R) 0.19017
Lymph node A 0.04051**
Lymph node C 0.04054**
Lymph node T 0.13150*
Lymph node GC 0.04081**
Lymph node A1 0.04425**
Lymph node C1 0.12186*
Lymph node A2 0.11308*
Lymph node C2 0.13804*
Lymph node G2 0.04205**
Lymph node T2 0.09620**
Lymph node AAA 0.17294
Lymph node AAT 0.14063*
Lymph node ATG 0.07070**
Lymph node CCC 0.09825**
Lymph node CTT 0.14385*
Lymph node GAT 0.18424
Lymph node GCC 0.09051**
Lymph node GCG 0.12512*
a
* means the feature is signiﬁcant when the FDR is controlled at a level of 1
level of 10%; blank (without asterisk) means the FDR is controlled at a leveIt is interesting to note that diﬀerent tissues may have com-
mon most signiﬁcant features (Table 1). For instance, the fea-
tures G2, GTC and His appear in three tissues, respectively,
while ACG is shared by two tissues, which provide further evi-
dence to support the above opinion that common mechanisms
may be responsible for the gene expression regulation in diﬀer-
ent tissues.
3.3. The truly interesting features identiﬁed by FDR analysis
To pinpoint which features are truly interesting, FDR is con-
trolled below a level of 20% and the correlations with q-values
less than 0.2 are listed in Table 2. Totally, 57 interesting fea-
tures in 10 tissues were identiﬁed by FDR analysis, most of
which (35) concentrate in lymph node (covering all of the four
categories of sequence compositional features). Bone marrow
and testis are the second largest holders (both 5) of signiﬁcant
feature. The other 12 signiﬁcant features are shared by liver
(4), mammary gland (2), pancreas (2), bone (1), embryonic tis-
sue (1), ovary (1) and uterus (1), respectively.
Notably, some features common among multiple tissues still
hold (Table 2). For example, the nucleotide compositional fea-
ture G2 (guanine at the second codon position) is commonly
signiﬁcant in ﬁve tissues (bone marrow, liver, lymph node,
mammary gland, and testis); the codon frequency feature
GTC is common in ovary and pancreas; the amino acid fre-
quency feature Met is common in liver and lymph node; and
the synonymous codon usage feature AGG(R) is common in
bone marrow and liver. It should be noticed that the most
signiﬁcant features in each tissue listed in Table 1 also appear
in Table 2 if that tissue has passed the FDR control. OurTissue Feature q-valuea
Lymph node GGC 0.19683
Lymph node TAT 0.12217*
Lymph node TGC 0.08246**
Lymph node Asp 0.13155*
Lymph node Gly 0.14262*
Lymph node Ile 0.12387*
Lymph node Lys 0.12429*
Lymph node Met 0.06588**
Lymph node Pro 0.15700
Lymph node TGC(C) 0.19115
Lymph node TGT(C) 0.19115
Lymph node CAC(H) 0.19263
Lymph node CAT(H) 0.19263
Lymph node CTT(L) 0.14223*
Lymph node AAC(N) 0.18562
Lymph node AAT(N) 0.18562
Lymph node CCC(P) 0.16979
Mammary gland G2 0.14361*
Mammary gland ACA 0.18861
Ovary GTC 0.13594*
Pancreas GTC 0.17210
Pancreas ATC(I) 0.18694
Testis G2 0.11192*
Testis AAA 0.19193
Testis CGC 0.09862**
Testis TGC 0.05767**
Testis CGC(R) 0.13362*
Uterus His 0.16851
– – –
5%; ** mean the feature is signiﬁcant when the FDR is controlled at a
l of 20%. For a complete list of q-values, see Supplementary Table 4.
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(P < 0.01) that have passed the FDR control (namely,
q < 0.2) to ensure the ‘‘trueness’’ of the correlations.4. Discussion
The above analyses identiﬁed signiﬁcant correlations
between oncogene tissue-speciﬁc expressions and sequence
compositional features, some of which provide new clues to
understanding the translational selection on sequence features
of human genes. First, it is observed that synonymous codon
usage feature AGG (coding for arginine) is signiﬁcantly corre-
lated with the oncogene expression levels in bone marrow
(rS = 0.45, P = 0.00122) (Tables 1 and 2) and liver (rS = 0.37,
P = 0.00314) (Table 2, Supplementary Tables 2 and 3). An-
other two arginine-coding codons CGT and CGC are also sig-
niﬁcant in salivary gland (rS = 0.49, P = 0.00499) (Table 1) and
testis (rS = 0.37, P = 0.00107) (Table 2, Supplementary
Tables 2 and 3), respectively. As the degeneracy degree of
arginine is six, it can be inferred that the codon usage is biased
in the four tissues, which suggests the existence of translational
selection on synonymous codon pattern. Second, it can be
found that the GC content at third codon (GC3) is in nearly
signiﬁcant correlation (rS = 0.31, P = 0.01896) (Supplemen-
tary Tables 2 and 3) with the oncogene expression level in
lymph node. Compared with Duret’s observation that a weak
negative correlation (rS = 0.06, P = 0.03) exists between GC3
and the maximum expression level of genes among human tis-
sues [21], the present work reveals a much higher correlation.
Since the variability of synonymous codon usage is reﬂected
essentially by GC3, this ﬁnding also supports the translational
selection in some tissues of human.
The correlations between synonymous codon usage and gene
expression levels are usually attributed to the higher abun-
dance of isoaccepting tRNA for optimal codons to maximize
translational eﬃciency both in unicellular [22,23] and in multi-
cellular [24–27] organisms, which may also account for the
presently observed correlations because it has been revealed re-
cently that diﬀerent human tissues have diﬀerent relative
tRNA abundance with a maximum range of tenfold variation
[28]. The association of phase-speciﬁc base compositional fea-
tures with gene expression levels may reﬂect the corresponding
codon usage frequencies. For example, G2 is observed signiﬁ-
cantly correlating to expression levels in multiple tissues (bone
marrow, liver, lymph node, testis, etc.). Meanwhile, it can be
found that some codon frequency features or synonymous
codon usage features that carry guanine at the second codon
position also display signiﬁcant correlations with expression
levels in these tissues (Table 2), indicating that nucleotide com-
positional features are proxies of the corresponding codon
usage pattern and can synthesize the codon frequency informa-
tion. Besides the synonymous codon usage and base composi-
tional features, there are also some amino acid composition
features showing signiﬁcant correlations with the expression
levels of human oncogenes (Table 2). For example, Asp and
Lys in lymph node exhibit positive correlations (rS = 0.42,
P = 0.00100 and rS = 0.43, P = 0.00082, respectively) with
oncogene expression levels, while His in uterus shows negative
correlation (rS = 0.35, P = 0.00218) (Table 2, Supplementary
Tables 2 and 3), implying that highly expressed genes andpoorly expressed genes are diﬀerent to some extent in amino
acid composition. This result is congruent with the previous
conclusion stemming from an investigation of overall human
genes [29].
The signiﬁcant correlations between sequence features and
mRNA expression level of oncogenes also have important
implications for understanding the molecular mechanisms of
tissue-speciﬁc oncogenesis. The ﬁrst noticeable fact is that, as
the ﬁrst site of cancer spread process [30,31], lymph node has
the largest number of signiﬁcant features that correlate with
oncogene expression levels (Table 2), which may provide valu-
able information for understanding the mechanisms of cancer
metastasis through the lymphatic system. Another noticeable
ﬁnding involves the synonymous codons coding for arginine
(Table 2), supporting the close relationship between NO (nitric
oxide)-mediated arginine metabolism and tumor formation
[32,33] and provoking interest of further investigation. Previ-
ous studies indicated that some codons play important roles
in determining the level of oncogene’s expression. For
instance, the mutation from GGC to GTC in codon 12 of
H-ras-1 oncogene aﬀects more than 80% of the tumor cells
and could be used as a further genomic marker and discrimi-
nation factor of sarcomas [34]. The mutation of RET proto-
oncogene codon 918 (ATG–ACG) is strongly correlated with
poor prognosis (P < 104) [35] and has a prognostic impact
on patients with sporadic medullary thyroid carcinoma, which
may inﬂuence the continuative therapy [36]. It is interesting to
note that both codons GTC and ACG are indeed positively
correlated with the oncogene expression levels in four and
two tissues, respectively (Table 1, Supplementary Tables 2
and 3), and some of them have passed the FDR control (Table
2). Besides, the present analyses identiﬁed AAA, GGC, TGC
signiﬁcant in multiple tissues (Table 2 and Supplementary
Table 2), which is of signiﬁcance to selecting markers of
tissue-speciﬁc oncogenesis in future studies.
In summary, through analyzing the correlations between tis-
sue-speciﬁc oncogene expressions and sequence compositional
features in human tissues, some signiﬁcant correlations have
been identiﬁed. Some of them provide new evidence to support
the existence of translational selection on synonymous codon
usage pattern, at least to human oncogenes in certain tissues
and some have important implications for diagnosis of can-
cers.
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